United States Healthcare Equipment & Supplies

Lucid Diagnostics Inc (LUCD)

Track

Lucid Diagnostics Inc. recorded a single insider purchase valued at approximately $245,270 over the past ninety days. This acquisition occurred shortly after the company reported its latest earnings results, which missed expectations by over ten percent. The stock price has declined by 5.2% during this period, currently trading near its yearly lows.
Ticker: LUCD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lucid Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Matheis Dennis Non-Executive Director
Transaction date
Purchase
Price
128.43
Quantity 29,043 +14.3%
Value US$4,897,925
2.0
Matheis Dennis Non-Executive Director
Transaction date
Purchase
Price
259.87
Quantity 44,117 -49.9%
Value US$2,256,960
2.0
Matheis Dennis Non-Executive Director
Transaction date
Purchase
Price
496.81
Quantity 82,752 -30.2%
Value US$3,742,378
2.0
Matheis Dennis Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 129,684 +69.3%
Value US$171,520
2.0
Matheis Dennis Non-Executive Director
Transaction date
Purchase
Price
1.30
Quantity 187,098 +inf%
Value US$242,292
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Planned sale
Price
1.45
Quantity 9,747 -8.8%
Value US$14,133
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Planned sale
Price
1.43
Quantity 10,000 -8.2%
Value US$14,300
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Planned sale
Price
1.47
Quantity 10,000 -7.6%
Value US$14,740
2.9
Stanley N. Lapidus Director Non-Executive Director
Transaction date
Proposed sale
Price
1.45
Quantity 33,864
Value US$49,103
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Planned sale
Price
1.43
Quantity 200 -0.2%
Value US$286
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Sale
Price
1.44
Quantity 100 -0.1%
Value US$144
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Sale
Price
1.44
Quantity 412 -0.3%
Value US$593
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Sale
Price
1.45
Quantity 3,405 -2.5%
Value US$4,937
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Sale
Price
1.70
Quantity 16,864 -11.1%
Value US$28,669
2.9
Lapidus Stanley Non-Executive Director
Transaction date
Sale
Price
1.71
Quantity 17,000 -10.0%
Value US$29,014
PAVmed Inc. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 571,428 +2.1%
Value US$7,999,992
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-20 B Purchase
2.0
Matheis Dennis
Non-Executive Director
29,043 +14.3%
128.43
US$4,897,925 		29,043 +14.3% 128.43 US$4,897,925
2025-08-22 2025-08-20 B Purchase
2.0
Matheis Dennis
Non-Executive Director
44,117 -49.9%
259.87
US$2,256,960 		44,117 -49.9% 259.87 US$2,256,960
2025-05-22 2025-05-22 B Purchase
2.0
Matheis Dennis
Non-Executive Director
82,752 -30.2%
496.81
US$3,742,378 		82,752 -30.2% 496.81 US$3,742,378
2025-05-22 2025-05-21 B Purchase
2.0
Matheis Dennis
Non-Executive Director
129,684 +69.3%
1.32
US$171,520 		129,684 +69.3% 1.32 US$171,520
2025-05-22 2025-05-20 B Purchase
2.0
Matheis Dennis
Non-Executive Director
187,098 +inf%
1.30
US$242,292 		187,098 +inf% 1.30 US$242,292
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
9,747 -8.8%
1.45
US$14,133 		9,747 -8.8% 1.45 US$14,133
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
10,000 -8.2%
1.43
US$14,300 		10,000 -8.2% 1.43 US$14,300
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
10,000 -7.6%
1.47
US$14,740 		10,000 -7.6% 1.47 US$14,740
2023-09-26 2023-09-26 PrS Proposed sale
2.9
Stanley N. Lapidus

Director

Non-Executive Director
33,864
1.45
US$49,103 		33,864 1.45 US$49,103
2023-09-27 2023-09-25 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
200 -0.2%
1.43
US$286 		200 -0.2% 1.43 US$286
2023-09-22 2023-09-21 S Sale
2.9
Lapidus Stanley
Non-Executive Director
100 -0.1%
1.44
US$144 		100 -0.1% 1.44 US$144
2023-09-22 2023-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
412 -0.3%
1.44
US$593 		412 -0.3% 1.44 US$593
2023-09-22 2023-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
3,405 -2.5%
1.45
US$4,937 		3,405 -2.5% 1.45 US$4,937
2022-09-22 2022-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
16,864 -11.1%
1.70
US$28,669 		16,864 -11.1% 1.70 US$28,669
2022-09-22 2022-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
17,000 -10.0%
1.71
US$29,014 		17,000 -10.0% 1.71 US$29,014
2021-10-20 2021-10-18 B Purchase
PAVmed Inc.
Large shareholder
571,428 +2.1%
14.00
US$7,999,992 		571,428 +2.1% 14.00 US$7,999,992
Explore more

More insider trading research around Lucid Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America